The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Precision Genomic Testing Market From 2026 To 2030?
The precision genomic testing market size has seen a rapid increase in recent years. It is anticipated to grow from $15 billion in 2025 to $16.75 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.7%. The expansion observed in the past can be attributed to several factors, including advancements in sequencing technologies, the broader implementation of precision oncology programs, the increasing accessibility of genomic databases, a rise in clinical research funding, and a heightened awareness of genetic disorders.
The precision genomic testing market is anticipated to show significant expansion in the coming years. It is projected to achieve a size of $25.71 billion by 2030, driven by a compound annual growth rate (CAGR) of 11.3%. This growth during the forecast period is primarily due to the increased adoption of precision medicine, rising investments in genomic research, the expansion of population-scale genomic initiatives, a growing demand for companion diagnostics, and the increasing integration of genomics into routine clinical practice. Notable trends during this period are expected to include the increasing adoption of next-generation sequencing, a rise in the use of AI-based genomic interpretation, a growing demand for personalized treatment planning, the expansion of clinical genomic testing, and enhanced integration of bioinformatics platforms.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25883&type=smp
What Major Factors Are Driving The Precision Genomic Testing Market Forward?
The increasing occurrence of genetic conditions is anticipated to drive the expansion of the precision genomic testing market in the future. Genetic disorders are defined as health issues stemming from anomalies in an individual’s DNA, including single-gene mutations, multi-gene mutations, or alterations in chromosomal arrangement or quantity. This rise in prevalence largely stems from an increase in maternal age, given that older mothers face an elevated risk of transmitting chromosomal irregularities, such as Down syndrome, to their offspring. Precision genomic testing facilitates the prompt identification and precise diagnosis of genetic disorders through pinpointing specific genetic mutations, thereby enabling focused interventions and customized treatment plans. For example, in May 2025, Gene People, a registered charity located in the UK, reported that genetic conditions impact approximately 1 in 25 children, affecting more than 2.4 million children and adults across the UK. Furthermore, roughly 30,000 newborns and children within the UK receive a diagnosis of a genetic condition annually. Consequently, the increasing incidence of genetic disorders is fueling the expansion of the precision genomic testing market.
Which Segment Classifications Are Used In The Precision Genomic Testing Market Segment Analysis?
The precision genomic testing market covered in this report is segmented –
1) By Product And Service: Consumables, Equipment, Services
2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray Technology, Sanger Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats Or Clustered Regularly Interspaced Short Palindromic Repeats-Associated Systems, Other Technologies
3) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Reproductive Health, Rare Diseases, Other Applications
4) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End-Users
Subsegments:
1) By Consumables: Reagents And Kits, Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Library Preparation Kits, Sequencing Reagents, Polymerase Chain Reaction Assay Kits, Buffers And Enzymes
2) By Equipment: Next-Generation Sequencing Systems, Polymerase Chain Reaction Machines, Microarray Instruments, Deoxyribonucleic Acid Analyzers, Bioinformatics Workstations, Laboratory Automation Systems
3) By Services: Genomic Data Analysis Services, Laboratory Testing Services, Genetic Counseling Services, Clinical Interpretation Services, Contract Research Services, Custom Assay Development Services
Which Trends Are Impacting The Progress Of The Precision Genomic Testing Market?
Major companies operating within the precision genomic testing market are concentrating on developing groundbreaking solutions, including highly sensitive circulating tumor deoxyribonucleic acid assays, to facilitate earlier and more accurate cancer detection. These ultra-sensitive circulating tumor deoxyribonucleic acid assays are advanced diagnostic tools designed to identify minuscule fragments of tumor-derived deoxyribonucleic acid present in the blood, enabling the prompt and precise identification of genetic mutations linked to cancer. For instance, in April 2025, Natera Inc., a clinical genetic testing company based in the US, introduced its ultra-sensitive Signatera genome molecular residual disease test. This test leverages whole genome sequencing of both a patient’s tumor and their matched normal deoxyribonucleic acid to construct a personalized assay, allowing for the detection of circulating tumor deoxyribonucleic acid at incredibly low concentrations, down to 1 part per million. This exceptional level of sensitivity supports the earlier and more accurate identification of cancer recurrence, thereby enhancing treatment planning and patient management across various forms of cancer.
Which Firms Are Contributing To The Precision Genomic Testing Market Ecosystem?
Major companies operating in the precision genomic testing market are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Ambry Genetics Corporation, Color Health Inc., Pacific Biosciences, Eurofins Genomics LLC, BGI Genomics Co. Ltd.
Get The Full Precision Genomic Testing Market Report:
https://www.thebusinessresearchcompany.com/report/precision-genomic-testing-global-market-report
Which Region Is The Largest In The Precision Genomic Testing Market?
North America was the largest region in the precision genomic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision genomic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Precision Genomic Testing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/precision-genomic-testing-global-market-report
Browse Through More Reports Similar to the Global Precision Genomic Testing Market 2026, By The Business Research Company
Precision Medicine Market Report 2026
https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report
Clinical Diagnostics Market Report
https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report
Precision Parts Market Report
https://www.thebusinessresearchcompany.com/report/precision-parts-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model